Busund LT - Search Results

1

Chromosome abnormalities in juxtaglomerular cell tumors.

Brandal P, Busund LT, Heim S. Brandal P, et al. Among authors: busund lt. Cancer. 2005 Aug 1;104(3):504-10. doi: 10.1002/cncr.21205. Cancer. 2005. PMID: 15968688 Free article.

2

Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients.

Al-Saad S, Al-Shibli K, Donnem T, Andersen S, Bremnes RM, Busund LT. Al-Saad S, et al. Among authors: busund lt. J Thorac Oncol. 2010 Oct;5(10):1536-43. doi: 10.1097/JTO.0b013e3181ea510a. J Thorac Oncol. 2010. PMID: 20802349 Free article.

3

Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival.

Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, Al-Saad S, Andersen S, Stenvold H, Bremnes RM, Busund LT. Donnem T, et al. Among authors: busund lt. Cancer. 2011 Jul 15;117(14):3193-200. doi: 10.1002/cncr.25907. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264844 Free article.

4

Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript.

Berg T, Kalsaas AH, Buechner J, Busund LT. Berg T, et al. Among authors: busund lt. Cancer Genet Cytogenet. 2009 Oct;194(1):53-7. doi: 10.1016/j.cancergencyto.2009.06.002. Cancer Genet Cytogenet. 2009. PMID: 19737655

5

Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer.

Donnem T, Al-Shibli K, Andersen S, Al-Saad S, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. Cancer. 2010 Sep 15;116(18):4318-25. doi: 10.1002/cncr.25333. Cancer. 2010. PMID: 20549821 Free article.

6

Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study.

Duell EJ, Lujan-Barroso L, Sala N, Deitz McElyea S, Overvad K, Tjonneland A, Olsen A, Weiderpass E, Busund LT, Moi L, Muller D, Vineis P, Aune D, Matullo G, Naccarati A, Panico S, Tagliabue G, Tumino R, Palli D, Kaaks R, Katzke VA, Boeing H, Bueno-de-Mesquita HBA, Peeters PH, Trichopoulou A, Lagiou P, Kotanidou A, Travis RC, Wareham N, Khaw KT, Ramon Quiros J, Rodríguez-Barranco M, Dorronsoro M, Chirlaque MD, Ardanaz E, Severi G, Boutron-Ruault MC, Rebours V, Brennan P, Gunter M, Scelo G, Cote G, Sherman S, Korc M. Duell EJ, et al. Among authors: busund lt. Int J Cancer. 2017 Sep 1;141(5):905-915. doi: 10.1002/ijc.30790. Epub 2017 Jun 12. Int J Cancer. 2017. PMID: 28542740 Free PMC article.

7

Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.

Donnem T, Andersen S, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. Cancer. 2010 Dec 15;116(24):5676-85. doi: 10.1002/cncr.25551. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737536 Free article.

8

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.

Paulsen EE, Kilvaer TK, Rakaee M, Richardsen E, Hald SM, Andersen S, Busund LT, Bremnes RM, Donnem T. Paulsen EE, et al. Among authors: busund lt. Cancer Immunol Immunother. 2017 Nov;66(11):1449-1461. doi: 10.1007/s00262-017-2039-2. Epub 2017 Jul 13. Cancer Immunol Immunother. 2017. PMID: 28707078 Free PMC article.

9

Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.

Donnem T, Hald SM, Paulsen EE, Richardsen E, Al-Saad S, Kilvaer TK, Brustugun OT, Helland A, Lund-Iversen M, Poehl M, Olsen KE, Ditzel HJ, Hansen O, Al-Shibli K, Kiselev Y, Sandanger TM, Andersen S, Pezzella F, Bremnes RM, Busund LT. Donnem T, et al. Among authors: busund lt. Clin Cancer Res. 2015 Jun 1;21(11):2635-43. doi: 10.1158/1078-0432.CCR-14-1905. Epub 2015 Feb 13. Clin Cancer Res. 2015. PMID: 25680376

10

Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.

Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM. Donnem T, et al. Among authors: busund lt. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6649-57. doi: 10.1158/1078-0432.CCR-07-0414. Clin Cancer Res. 2007. PMID: 18006765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page